Orchestra BioMed Holdings, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Orchestra BioMed Holdings, Inc. (OBIO) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 20.45 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-03-31
- Orchestra BioMed Holdings, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 20.45M shares.
- Orchestra BioMed Holdings, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 20.45M shares, a 48.09% increase year-over-year.
- Orchestra BioMed Holdings, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 16.00M shares.
- Orchestra BioMed Holdings, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 16.00M shares.
- Orchestra BioMed Holdings, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 20.45M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 4 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 4 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 7 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | 20.45M shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-03-31 | 20.45M shares derived: average of 2 quarters · filed 2022-03-31 | 18.97M shares derived: average of 3 quarters · filed 2022-03-31 | 20.45M shares 10-K · filed 2022-03-31 | ||||
| 2021-09-30 | 20.45M shares 10-Q/A · filed 2022-03-31 | 18.23M shares derived: average of 2 quarters · filed 2022-03-31 | 20.45M shares 10-Q/A · filed 2022-03-31 | |||||
| 2021-06-30 | 16.00M shares 10-Q · filed 2021-08-16 | 16.00M shares 10-Q · filed 2021-08-16 | ||||||
| 2021-03-31 | 16.00M shares 10-Q · filed 2021-05-17 | |||||||
| 2020-12-31 | 16.00M shares 10-K · filed 2021-03-10 | |||||||
| 2020-09-30 | 13.81M shares 10-Q/A · filed 2022-03-31 | 16.00M shares 10-Q · filed 2020-11-05 | 11.96M shares 10-Q/A · filed 2022-03-31 | 16.00M shares 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |